Sign up here to receive news updates via email.
-
September 8, 2020 |
Media, Press Releases
BERG’s Study Provides Biological Insights Into The Increased Incidence Of COVID-19 In The African American Population
read moreStudy Indicates Strong Rationale for Use of ACE Inhibitors and ARBs in Clinical Management News provided by BERG Health Sep 08, 2020, 19:16 ET FRAMINGHAM, Mass., Sept. 8, 2020 /PRNewswire/ — BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, today announced the results of a COVID-19…
-
June 22, 2020 |
Media, Press Releases
BERG Announces Presentation Of Multiple Interrogative Biology Platform® And Outputs From Multiple Collaborations At AACR
read moreNews provided by BERG Health Jun 22, 2020, 09:00 ET FRAMINGHAM, Mass., June 22, 2020 /PRNewswire/ — BERG, a clinical-stage biotech that employs artificial intelligence (AI) to research diseases and develop innovative treatments, today announced five presentations at the American Association for Cancer Research (AACR) Virtual Annual Meeting, being held from June 22- 24, 2020. Two…
-
June 17, 2020 |
Media, Press Releases
BERG Creates New Drug Research Effort to Use Oak Ridge National Laboratory’s Summit Supercomputer in the Fight Against COVID-19
read moreTeam Will Accelerate and Transform COVID-19 Drug Discovery Process NEWS PROVIDED BY BERG June 17, 2020, 09:00 ET FRAMINGHAM, Mass., June 17, 2020 /PRNewswire/ — BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, today announced an agreement to tap the revolutionary Summit supercomputer at the Department of…
-
June 1, 2020 |
Media, Press Releases
BERG Presents Results of Phase 1 Clinical Study in Glioblastoma at 2020 American Society of Clinical Oncology (ASCO) Meeting
read moreStudy Demonstrates Safety and Tolerability and its Potential Impact on Metabolism to Elicit Anti-Cancer Response in Brain Cancer NEWS PROVIDED BY BERG Jun 01, 2020, 09:05 ET FRAMINGHAM, Mass., June 1, 2020 /PRNewswire/ — BERG, a clinical-stage biotech company that uses Artificial Intelligence (AI) to research diseases and develop innovative treatments, today announced results from a…
-
May 6, 2020 |
Media, Press Releases
BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions
read moreBERG will pair its Interrogative Biology® Platform with Boehringer Ingelheim’s Translational Medicine and Biomarker Expertise News provided by BERG Health May 06, 2020, 09:00 ET FRAMINGHAM, Mass., May 6, 2020 /PRNewswire/ — BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, today announced a new collaboration with…
-
April 13, 2020 |
Media, Press Releases
BERG Named Visionary in Frost & Sullivan’s First-Ever Frost Radar™ AI in Drug Discovery Report in the Pharmaceutical Industry
read moreBERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, has been awarded a spot in Frost & Sullivan’s first-ever Frost Radar™ AI in Drug Discovery report in the pharmaceutical industry. News provided by BERG Apr 13, 2020, 14:25 ET FRAMINGHAM, Mass., April 13, 2020 /PRNewswire/ — BERG, a…
